✨ Free AI Report
Nevro Corp: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Research Preview

Nevro Corp: Business Overview, Financials & Competitive Analysis

Nevro Corp is a medical device company whose key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pa...

Analyst-debate audio for Nevro Corp

AskCyborg analysts argue the bull and bear cases for Nevro Corp across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Nevro Corp OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Nevro Corp Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Nevro Corp Overview

Pro stress-test →

Nevro Corp is a medical device company whose key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. The company was acquired by Globus Medical, a leading musculoskeletal technology company, with the acquisition completed on April 3, 2025.

Strategic Profile

Pro stress-test →

The Senza SCS system generates electrical impulses to relieve pain, is implanted by physicians and controlled by patients. The acquisition expanded Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity in neuromodulation and spinal cord stimulation therapies.

Competitive Landscape

Pro stress-test →

In the spinal cord stimulation market, Nevro competed with Boston Scientific, Abbott, and emerging innovators in neuromodulation. Its 10 kHz proprietary HF10 therapy provided clinical differentiation in the chronic pain treatment space.

Industry Context

Nevro Corp operates in Medical Devices - Neuromodulation & Spinal Cord Stimulation.

Key facts

Founded: 2006 · Headquarters: Redwood City, CA, United States · Revenue: $408.52 million (last reported annual revenue)

What the analysts stress-tested

The top findings that survived the multi-agent debate for Nevro Corp.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Nevro Corp has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Spinal ModulationSpinal cord stimulation and neuromodulation therapiesNeuromodulationSpinal cord stimulation and chronic pain solutionsSpine SolutionsMusculoskeletal and surgical spine technologies

Compare Nevro Corp with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Nevro Corp operates in Medical Devices - Neuromodulation & Spinal Cord Stimulation. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Neuromodulation & Spinal Cord Stimulation research →
NEW · MCP server

Ask your AI assistant about Nevro Corp

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Nevro Corp and its top competitor on Cyborg Score”
“What did Nevro Corp do this quarter?”
“Is Nevro Corp a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Nevro Corp do?+
Nevro Corp is a medical device company whose key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pa...
What is Nevro Corp's Cyborg Score?+
The Cyborg Score is a 1-10 rating from the AskCyborg multi-agent analyst-debate framework. Recalibrated weekly across business, financials, leadership, competitive position, technology, marketing, and ESG dimensions.
Who are Nevro Corp's main competitors?+
Named competitors include Spinal Modulation, Neuromodulation, Spine Solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full Nevro Corp research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Nevro Corp research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.